CCIA
NVO

Campbell & Co Investment Adviser’s Novo Nordisk NVO Stock Holding History

Campbell & Co Investment Adviser’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-53,853
Closed -$2.74M – 1312
2025
Q4 		$2.74M Buy
53,853
+33,850
+169% +$1.73M 0.13% 239
2025
Q3 		$1.11M Buy
20,003
+10,819
+118% +$633K 0.08% 381
2025
Q2 		$634K Sell
9,184
-35,785
-80% -$2.43M 0.04% 703
2025
Q1 		$3.12M Buy
44,969
+39,923
+791% +$3.3M 0.24% 90
2024
Q4 		$434K Sell
5,046
-5,632
-53% -$609K 0.03% 707
2024
Q3 		$1.27M Sell
10,678
-5,726
-35% -$764K 0.09% 347
2024
Q2 		$2.34M Sell
16,404
-14
-0.1% -$1.85K 0.2% 126
2024
Q1 		$2.11M Buy
+16,418
New +$1.95M 0.18% 131
2023
Q4 		– Sell
-5,219
Closed -$475K – 1275
2023
Q3 		$475K Sell
5,219
-7,945
-60% -$700K 0.06% 537
2023
Q2 		$1.07M Sell
13,164
-7,574
-37% -$619K 0.19% 130
2023
Q1 		$1.65M Buy
+20,738
New +$1.47M 0.31% 44
2022
Q4 		– Sell
-6,704
Closed -$334K – 928
2022
Q3 		$334K Sell
6,704
-866
-11% -$46.4K 0.08% 445
2022
Q2 		$422K Buy
+7,570
New +$420K 0.11% 331
2021
Q1 		– Sell
-5,734
Closed -$200K – 558
2020
Q4 		$200K Buy
+5,734
New +$198K 0.12% 366
2019
Q2 		– Sell
-9,724
Closed -$254K – 652
2019
Q1 		$254K Buy
9,724
+734
+8% +$18K 0.12% 342
2018
Q4 		$229K Sell
8,990
-5,822
-39% -$129K 0.23% 253
2018
Q3 		$349K Buy
+14,812
New +$361K 0.24% 160
2013
Q3 		– Sell
-37,960
Closed -$588K – 332
2013
Q2 		$588K Buy
+37,960
New +$632K 0.11% 197

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Campbell & Co Investment Adviser's NVO Position: Q1 2026 in Review

Campbell & Co Investment Adviser sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 53,853 shares — an estimated $2.74M sold.

Campbell & Co Investment Adviser first reported a position in NVO in Q2 2013 and held it in 18 quarters. The position peaked at $3.12M in Q1 2025. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Campbell & Co Investment Adviser reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 53,853 Novo Nordisk shares in Q1 2026, an estimated $2.74M.
  • Campbell & Co Investment Adviser first reported a position in Novo Nordisk in Q2 2013 and held it in 18 quarters.
  • Campbell & Co Investment Adviser's Novo Nordisk position peaked at $3.12M in Q1 2025.
  • 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.